NL6601472A - - Google Patents

Info

Publication number
NL6601472A
NL6601472A NL6601472A NL6601472A NL6601472A NL 6601472 A NL6601472 A NL 6601472A NL 6601472 A NL6601472 A NL 6601472A NL 6601472 A NL6601472 A NL 6601472A NL 6601472 A NL6601472 A NL 6601472A
Authority
NL
Netherlands
Application number
NL6601472A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6601472A publication Critical patent/NL6601472A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6601472A 1965-02-08 1966-02-04 NL6601472A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43116465A 1965-02-08 1965-02-08

Publications (1)

Publication Number Publication Date
NL6601472A true NL6601472A (es) 1966-08-09

Family

ID=23710761

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6601472A NL6601472A (es) 1965-02-08 1966-02-04

Country Status (4)

Country Link
US (1) US3482015A (es)
DE (1) DE1617610C3 (es)
GB (1) GB1089043A (es)
NL (1) NL6601472A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
IL131492A0 (en) * 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
US20050187303A1 (en) * 2002-09-26 2005-08-25 Wu Men-Dar Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
AU2003266644B2 (en) * 2002-09-26 2008-04-03 Men-Dar Wu Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL289785A (es) * 1962-11-29
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
GB1114313A (en) * 1964-11-19 1968-05-22 Wyeth John & Brother Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DE1617610B2 (de) 1974-06-20
US3482015A (en) 1969-12-02
GB1089043A (en) 1967-11-01
DE1617610A1 (de) 1972-04-20
DE1617610C3 (de) 1975-01-30

Similar Documents

Publication Publication Date Title
BE674763A (es)
JPS4119837Y1 (es)
FR2105076A6 (es)
BE666658A (es)
BE675054A (es)
BE665425A (es)
BE665442A (es)
BE665569A (es)
BE665788A (es)
BE665895A (es)
BE666060A (es)
BE662383A (es)
BE688054A (es)
BE668816A (es)
BE668937A (es)
BE669446A (es)
BE669659A (es)
BE670578A (es)
BE671675A (es)
BE672252A (es)
BE672548A (es)
BE672703A (es)
BE672765A (es)
BE672829A (es)
BE672974A (es)